Tag: analyst

Reduced Funding Costs and GMV Growth to Bolster the Buy Now, Pay Later Pioneer Shares of Affirm Holdings (AFRM), a ...

Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided ...

Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in ...

Sales Fall Short of Expectations as the Company Navigates Inflation, Geopolitical Tensions, and Shifting Consumer Spending PepsiCo (PEP) has revised ...

What Investors Can Expect from Tesla's AI Innovations and Production Updates Tesla (TSLA) is gearing up for its much-anticipated AI ...

Potential Upside in Obesity Treatment as Higher Dose Efficacy Data Expected to Boost Competitive Profile Viking Therapeutics (VKTX) is gearing ...

Major trials signal potential advancements in cancer treatment and rare disease therapies Biotech companies are preparing for significant milestones as ...

Solid Sales Growth with Potential Speedbumps in the Final Quarter of 2024 Carvana (CVNA) continues to show resilience and momentum ...

Key Factors Supporting Continued Growth for EV Stocks in China China's electric vehicle (EV) market is undergoing a significant reset, ...

With Over 70 Royalty Streams, Ligand’s Unique Business Model Offers Compelling Opportunities for Investors Ligand Pharmaceuticals (LGND) is rapidly emerging ...